NeuPath Health Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was CAD 15.23 million compared to CAD 15.16 million a year ago. Net loss was CAD 1.08 million compared to CAD 0.66 million a year ago. Basic loss per share from continuing operations was CAD 0.02 compared to CAD 0.01 a year ago.
For the nine months, revenue was CAD 46.58 million compared to CAD 45.28 million a year ago. Net loss was CAD 2.33 million compared to CAD 2.51 million a year ago. Basic loss per share from continuing operations was CAD 0.05 compared to CAD 0.06 a year ago.